US-based firm Invivoscribe has announced the appointment of Masato Sasaki as General Manager of LabPMM GK, its reference laboratory in Japan. Sasaki brings a wealth of scientific experience with him as he served at Illumina K.K. (Japan) as a leader on their clinical next-generation sequencing (NGS) team, and at both Illumina K.K. and Qiagen K.K. where he introduced companion diagnostic (CDx) products in collaboration with pharmaceutical partners.

He also brings a deep understanding of Japanese culture, customs, and business practices, essential for growing Invivoscribe's business in Japan and APAC region.

Overseeing the overall operations of the company, Sasaki will ensure that LabPMM GK, a wholly owned subsidiary of Invivoscribe, meets its goals and objectives. He will also be involved in making strategic decisions to help the company grow and succeed, and will ensure LabPMM GK remains in compliance with applicable laws and regulations.

Further, in managing the team and leading by example, he will build and maintain relationships with other companies and organizations that are important to Invivoscribe's success with customers, internal and external stakeholders, and industry partners.